Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Latest Episodes:

Echo Lab: Managing Quality, Productivity, Efficiency and Innovation Apr 18, 2019

Show notes

Richard Grimm, DO, Director of the Echocardiography Laboratory, and Helga Lombardo, RDCS, FASE Supervisor, Echocardiography Lab, discuss many aspects of running a successful high volume echo lab.

Thoracic aorta disease in an asymptomatic primary prevention population Apr 11, 2019

Show notes

Dr. Milind Desai, Medical Director of the Aorta Center, discusses a recently published paper looking at a series of asymptomatic middle aged males who underwent chest computed tomographyalong with coronary artery calcium scoring as part of a comprehensive primary prevention evaluation. About 16% had a dilated aortic root when indexed to height. Dr. Desai discusses the implications of these findings. Study can be reviewed in Circulation. 2018;139:557–558

ACC 2019 Highlights: TAVR, Electrophysiology, Anti-thrombotic Therapies Apr 04, 2019

Show notes

A. Michael Lincoff, MD, Director of the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), reviews the results from clinical trials presented at the 2019 American College of Cardiology Conference focusing on three major practice areas: 1) the use of transcatheter aortic valves (TAVR) in low risk patients (PARTNER 3, Evolut Low); 2) electrophysiology studies (Apple Heart, WRAP-IT) ; and 3) anti-thrombotic therapies in patients with atrial fibrillation, acute coronary syndrome or percutaneous intervention (AUGUSTUS, GLASSY). Dr. Lincoff summarizes the studies’ design and results, and provides insight into the potential impact on future care of patients based on these outcomes.

A data-zone scoring system to assess the generalizability of clinical trial results Mar 28, 2019

Show notes

Luke Laffin, MD, cardiologist in the Section of Preventive Cardiology at Cleveland Clinic discusses his recently published paper with Stephanie Besser, MSA, MSPA, and Francis Alenghat, MD, PhD, from the University of Chicago which dove into the results of the SPRINT and ACCORD-BP trials to answer the question if trial results looking at a specific population of patients can apply to specific patients in clinic. The team developed a tool to answer this question.

Advances in hospital-based monitoring, analysis and responsiveness Mar 21, 2019

Show notes

Steven Nissen, MD talks with Daniel Cantillon, MD, staff electrophysiologist and Medical Director for Cleveland Clinic’s Central Monitoring Unit about advanced approaches to telemetry monitoring for hospitalized patients. Dr. Cantillon leads a large central monitoring unit with sophisticated technology and risk stratification tools, triage algorithms and protocols and a well-trained staff. Dr. Cantillon and Dr. Nissen discuss the factors measured, what goes into the algorithms and how this type of technology can prevent emergency events – or allow for treatment before an emergency event occurs; as well as hopes for future technology and research.

STEMI Outcomes in High Risk Populations Mar 14, 2019

Show notes

Dr. Venu Menon, Director of the Cardiac Intensive Care Unit and the Cardiovascular Fellowship Program talks with Dr. Anirudh Kumar, a second year cardiovascular fellow about his recent research related to two high risk populations of STEMI patients, those with cardiogenic shock and those who present with cardiac arrest who underwent PCI. The findings were shared related to short and long-term outcomes in these two patient populations. In addition, he describes how and if new STEMI protocols had an impact on these high risk patients.

Tall Rounds: Treatment of Bicuspid Aortic Valve Disease Mar 05, 2019

Show notes

Eric Roselli, MD, Director of the Aorta Center at Cleveland Clinic leads the discussion on treatment of bicuspid aortic valve (BAV) disease. Joanna Ghobrial, MD discusses family screening; Leonardo Rodriguez, MD reviews clinical presentation; Milind Desai, M D discusses imaging; Douglas Johnston, MD covers valve choice in the young patient; Amar Krishnaswamy, MD & Samir Kapadia, MD covers patient candidates for TAVR and valve-in-valve; and finally Vidyasagar Kalahasti, MD discusses connective tissue disorders in bicuspid aortic valve disease. After listening, join us for the Tall Rounds® presentation on Bicuspid Aortic Valve Disease.

Long Term Outcomes after Aortic Valve Surgery in Patients with Aortic Regurgitation Feb 28, 2019

Show notes

Cleveland Clinic cardiologist Dr. Milind Desai discusses a paper published in JACC Imaging studying 865 patients who underwent aortic valve surgery with severe aortic regurgitation. Baseline ejection fraction and LV strain were studied pre-procedure and post procedure to look at the impact of these values and overall mortality. Dr. Desai discusses the findings of the study and implications for future evaluation of patients with aortic regurgitation. The study can be reviewed in JACC Imaging.

Characteristics and Long Term Outcomes in Adults with Marfan Syndrome and Ascending Aorta Surgery Feb 21, 2019

Show notes

Dr. Lars Svensson, Chairman of the Sydell and Arnold Miller Heart and Vascular Institute discusses a recently published paper with Dr. Milind Desai, Medical Director of the Aorta Center, looking at a series of 491 Marfan Syndrome (MFS) patients who presented for both emergent and/or prophylactic aorta surgery. Dr. Svensson provides a review of the MFS guidelines regarding when to operate. Dr. Desai explains multi-modality imaging including echo, MRI and CT scan when determining timing for surgery. The findings of the study are reviewed as well as implications for future care of patients with MFS. Read the study in the Journal of the American College of Cardiology and learn more about Marfan syndrome at the Marfan Foundation.

Heart Failure Awareness Feb 14, 2019

Show notes

In honor of Heart Failure Awareness Week, Steven Nissen, MD, Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic talks with Randall Starling, MD, MPH, President of the Heart Failure Society of America (HFSA) and Jerry Estep, MD, Section Head of Heart Failure at Cleveland Clinic about what we need to know about heart failure – whether a patient or provider; including the extent that heart failure affects us, treatment options – from medications – to the newest devices and transplant, and differences in causes and/or presentation based on gender and race.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Related Podcasts

Links

Stay Connected